Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Other Non Operating Income (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Other Non Operating Income for 6 consecutive years, with -$3.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 1334.71% year-over-year to -$3.5 million, compared with a TTM value of -$4.8 million through Dec 2025, changed N/A, and an annual FY2025 reading of -$4.8 million, changed N/A over the prior year.
  • Other Non Operating Income was -$3.5 million for Q4 2025 at Treace Medical Concepts, down from -$612000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $4.5 million in Q2 2022 and bottomed at -$8.0 million in Q3 2022.
  • Average Other Non Operating Income over 5 years is -$559555.6, with a median of -$291000.0 recorded in 2024.
  • The sharpest move saw Other Non Operating Income soared 134.26% in 2023, then crashed 1334.71% in 2025.
  • Year by year, Other Non Operating Income stood at -$2.1 million in 2021, then crashed by 290.75% to -$8.0 million in 2022, then surged by 123.69% to $1.9 million in 2023, then crashed by 112.73% to -$242000.0 in 2024, then plummeted by 1334.71% to -$3.5 million in 2025.
  • Business Quant data shows Other Non Operating Income for TMCI at -$3.5 million in Q4 2025, -$612000.0 in Q3 2025, and -$424000.0 in Q2 2025.